mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
6e-06 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.28 |
7e-06 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
7e-06 |
mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
0.22 |
2e-05 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
3e-05 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
4e-05 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-05 |
mRNA |
CHIR-99021 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
5e-05 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
5e-05 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
5e-05 |